Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE Combined With Thermal Ablation for Large Hepatocellular Carcinoma
NCT02630108Phase 3Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hepatocellular carcinoma (HCC) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Overall Survival at 26 months. Status: unknown.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02630108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630108.